Skip to main content
OpenTrials
Completed

NCT Number: NCT05647083

The Effect of Massage on Diabetic Parameters

This research aims to investigate the effect of massage on diabetic foot risk, HbA1c and physiological parameters in individuals with type 2 diabetes. This randomized controlled experimental design will be carried out in Bolu Izzet Baysal State Hospital Köroğlu Unit Internal Medicine Polyclinic and Internal Medicine Service. According to power analysis, the minimum sample size was determined as 60 people, 30 of which were in the intervention group and 30 in the control group. Data collection tools include "Peripheral Neuropathy Sign and Symptom Score", "Ankle-Brachial Index (ABI)", "Glycemic Control Assessment (HbA1c)", "Physiological Parameters (blood pressure, heart rate and oxygen saturation)", "Inlow's 60-second Diabetic Food Screen". A total of 24 massage sessions will be applied to the intervention group, 2 times a week during the 12-week working period. Participants in the control group will continue their medical treatment protocols and massage will not be applied.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bolu Provincial Health Directorate Bolu Izzet Baysal State Hospital

Bolu, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being between 30-75 years old,
  • Diagnosed with diabetes at least 6 months ago,
  • Absence of irritation, ulceration in the areas where the massage will be applied (hands, feet and legs),
  • No problem in verbal communication,
  • Being able to speak Turkish,
  • No diagnosis of psychiatric disease,
  • Absence of amputation in the upper and lower extremities,
  • Having HbA1c test results in the last 1 week,
  • Not having had Covid-19 in the last 6 months
  • No experience of massage application in the last 1 month
  • Willingness to participate in the research

Exclusion criteria

  • Presence of diabetic ulcer and foot wound,
  • Irritation and ulceration in the areas where the massage will be applied (hands, feet and legs),
  • Having problems in verbal communication,
  • Not being able to speak Turkish,
  • Having a diagnosis of psychiatric illness.

Treatment and study plan

Massage therapy

Other

Classical massage will be applied to the hands and feet, which is expected to take an average of 30 minutes.

Primary outcomes

  1. Means of Peripheral Neuropathy Sign and Symptom Score

    Time frame: Change from baseline Neuropathy score at 3 months

    Peripheral neuropathy consists of two parts: symptom and symptom score. For the peripheral neuropathy symptom score;

    • Discomfort they feel in their feet,
    • Location of complaints,
    • The presence of complaints increases at night,
    • Time of occurrence of complaints and
    • 5 questions will be asked about how the complaints decreased. Peripheral neuropathy symptom score obtained from 5 questions was 0-2 points, "normal"; 3-4 points, "mild neuropathy"; 5-6 points, "moderate neuropathy"; A score of 7-9 will be considered "severe neuropathy".

    For peripheral neuropathy finding score; It will be determined based on four parameters including 1. Vibration sense, 2. Pimpiric test, 3. Achille tendon reflex, 4. Protective sensory examination

  2. Means of Ankle-Brachial Index Score

    Time frame: Change from baseline Ankle-Brachial Index score at 3 months

    It is calculated by dividing the tibialis posterior pressure by the brachial arterial pressure. The highest of the four measurements at the ankles and feet is divided by the two higher brachial measurements. The normal value is close to 1.

  3. Means of HbA1c (%)

    Time frame: Change from baseline HbA1c score at 3 months

    HbA1c values of the participants will be monitored as a glycemic control parameter. The HbA1c value will be evaluated at baseline and 3 months later, as it represents the three-month average blood glucose value. For the measurement of HbA1c, the test results within the last week will be taken from the participants at the beginning and a blood sample will be taken into ethylenediaminetetraacetic acid (EDTA) coated tubes (2 mL whole) by a nurse three months later.

  4. Means of systolic blood pressure (mmHg)

    Time frame: Change from baseline systolic blood pressure at 3 months

    It will be measured by the researcher with a manual measurement tool.

  5. Means of diastolic blood pressure (mmHg)

    Time frame: Change from baseline diastolic blood pressure at 3 months

    It will be measured by the researcher with a manual measurement tool.

  6. Means of heart rate (/minutes)

    Time frame: Change from baseline heart rate at 3 months

    It will be measured by the researcher with a pulse oximeter.

  7. Means of oxygen saturation (%)

    Time frame: Change from baseline oxygen saturation at 3 months

    It will be measured by the researcher with a pulse oximeter.

  8. Means of diabetic foot risk score

    Time frame: Change from baseline diabetic foot risk score at 3 months

    "Inlow's 60-second Diabetic Food Screen" form will be used in diabetes foot risk assessment. Diabetic foot examination consists of 12 parameters. Skin Assessment, Evaluation of Nail Structure, deformity, Evaluation of the Shoe, Heat Evaluation - Being Cold, Heat Evaluation - Being Hot, Range of Motion Evaluation, Sensory Evaluation, Sensory Evaluation (Assessment with questions directed to individuals), Evaluation of Pedal Pulses, Dependent Rubor Evaluation, Evaluation of Erythema (Redness). The minimum score to be taken from the foot examination form is evaluated as 0 and the maximum score as 23 points. The higher the score, the higher the risk of diabetic foot.

Sponsors and collaborators

Lead sponsor

Abant Izzet Baysal University

Other

Registry information

Official study title

The Effect of Massage on Diabetic Foot Risk, HbA1c and Physiological Parameters in People With Type 2 Diabetes

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Dec 12, 2022
Registry last updated
Apr 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.